Dental pulp regeneration represents a transformative frontier in endodontics, aiming to restore the vitality and function of the dental pulp complex after injury or disease. Recent advances in regenerative endodontic procedures (REPs), stem cell therapy, tissue engineering, and biomaterials have shifted the paradigm from traditional root canal therapies toward biologically based approaches. This review synthesizes current scientific evidence, elucidates the underlying mechanisms of pulp regeneration, discusses clinical applications, and highlights ongoing challenges and future perspectives for healthcare professionals.
The dental pulp is a vascularized and innervated connective tissue crucial for tooth vitality, immune defense, and reparative processes. Traditional endodontic treatments focus on the removal of infected or necrotic pulp, replacing it with inert materials. While effective in eradicating infection, these methods do not restore the biological function of the pulp-dentin complex. With advances in stem cell biology, tissue engineering, and biomaterials, dental pulp regeneration has emerged as a promising alternative, offering the potential for true tissue repair and functional restoration. This article provides a comprehensive overview of the epidemiology, pathophysiology, risk factors, clinical features, diagnostic approaches, management strategies, recent innovations, and guideline-based recommendations pertinent to dental pulp regeneration.
Pulpal and periapical diseases, such as irreversible pulpitis and pulp necrosis, are highly prevalent, particularly among pediatric and young adult populations. Dental caries remains the predominant etiological factor, with global prevalence rates for untreated carious lesions exceeding 30% in permanent dentition, according to WHO estimates. Traumatic dental injuries, especially in children and adolescents, further contribute to the burden by precipitating pulp necrosis. Endodontic diseases account for a significant proportion of dental visits, leading to substantial healthcare expenditures and impacting patients' quality of life. The high incidence of non-vital teeth, especially in populations lacking access to regular dental care, underscores the unmet need for regenerative alternatives that can restore both structure and function.
The dental pulp is a highly specialized tissue, comprising fibroblasts, odontoblasts, immune cells, blood vessels, and nerve fibers enclosed within rigid dentin walls. Injury from caries, trauma, or restorative procedures can disrupt the vascular supply, leading to inflammation, ischemia, and eventual necrosis. The loss of pulp tissue impairs the tooth's defense and reparative capacities, resulting in increased susceptibility to reinfection and structural compromise. Regeneration aims to recapitulate the native microenvironment by harnessing stem/progenitor cells, signaling molecules, and scaffolds to promote cell proliferation, differentiation, and tissue remodeling. The interplay of molecular signals, such as growth factors (e.g., TGF-β, BMPs, VEGF), and extracellular matrix components is critical in orchestrating pulp-dentin regeneration.
Key risk factors for pulp necrosis and subsequent need for regeneration include deep dental caries, extensive restorative procedures, traumatic injuries (luxation, avulsion), and iatrogenic damage during dental interventions. Patient factors such as age, immunocompetence, systemic health (e.g., diabetes mellitus), and genetic predispositions may influence both the susceptibility to pulpal disease and the potential for successful regeneration. Additionally, certain anatomical factors, like root development stage and apical foramen patency, play pivotal roles in the outcome of regenerative procedures.
Clinically, pulpal pathologies manifest as pain (spontaneous or provoked), sensitivity to thermal or electrical stimuli, discoloration, swelling, and, in advanced cases, periapical abscess formation. Vital pulp tissue is characterized by bleeding upon access, while necrotic pulp typically lacks responsiveness and may exhibit purulent exudate. In immature permanent teeth, pulp necrosis can arrest root development, resulting in short roots and thin dentinal walls, increasing the risk of fracture and tooth loss. Early detection and appropriate management are critical for optimizing regenerative outcomes.
Diagnosis of pulpal status relies on a combination of patient history, clinical examination, and adjunctive tests. Pulp vitality testing (thermal, electric, laser Doppler flowmetry), radiographic assessment (periapical, cone-beam computed tomography), and, in select cases, advanced imaging modalities are utilized to evaluate pulp health, root development, and periapical status. Careful case selection considering factors such as patient age, stage of tooth development, presence of infection, and apical anatomy is essential for successful pulp regeneration.
Conventional management of necrotic pulp involves root canal therapy, which eliminates infection but does not restore pulp vitality. Regenerative endodontic procedures (REPs) represent a biologically based alternative, particularly for immature teeth with necrotic pulps. REPs generally involve: (1) disinfection of the root canal system using irrigants (e.g., sodium hypochlorite, EDTA) and intracanal medicaments (e.g., calcium hydroxide, triple antibiotic paste); (2) induction of bleeding to introduce a blood clot scaffold rich in stem cells and growth factors; and (3) coronal sealing with biocompatible materials. The goal is to promote the ingrowth of new tissue capable of continued root development and functional recovery.
Recent technological and biological advances have accelerated progress in dental pulp regeneration. Stem cell-based strategies utilize dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHED), and other mesenchymal stem cell sources. Tissue engineering approaches employ biocompatible scaffolds (e.g., collagen, hydrogels, synthetic polymers) and controlled delivery of growth factors to enhance cell migration and differentiation. Gene therapy, 3D bioprinting, and nanotechnology are being explored to further refine regenerative protocols. Preclinical and early clinical studies report promising outcomes, including increased root length, dentin wall thickening, and restoration of pulp-like tissue. However, standardized protocols and long-term clinical data are still needed to ensure safety and efficacy.
Leading professional organizations, including the American Association of Endodontists (AAE) and European Society of Endodontology (ESE), advocate for case selection criteria, strict infection control, and the use of evidence-based protocols in pulp regeneration. Guidelines emphasize the importance of using irrigants and medicaments that are effective yet biocompatible, minimizing cytotoxicity to stem cells. Documentation of clinical and radiographic outcomes is essential for ongoing assessment. Adherence to consensus protocols and continuing education are recommended to optimize patient outcomes and advance the field.
Dental pulp regeneration heralds a paradigm shift in restorative dentistry, offering the potential for biologically based healing and functional recovery of teeth previously deemed non-vital. While significant progress has been achieved in understanding the cellular and molecular mechanisms of pulp regeneration, challenges remain in translating laboratory findings into predictable clinical therapies. Continued research, rigorous clinical trials, and guideline-driven practice are essential to realize the full potential of regenerative endodontics and improve patient care outcomes.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation